LOPINAVIR vs LORLATINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LOPINAVIR vs LORLATINIB: Safety Overview
| Metric | LOPINAVIR | LORLATINIB |
|---|---|---|
| Total FAERS Reports | 1,242 | 5,508 |
| Deaths Reported | 162 | 1,542 |
| Death Rate | 13.0% | 28.0% |
| Hospitalizations | 193 | 1,232 |
| Average Patient Age | 39.2 yrs | 56.5 yrs |
| % Female Patients | 32.7% | 54.0% |
| FDA Approval Date | N/A | Nov 2, 2018 |
| Manufacturer | AbbVie Inc. | Pfizer Laboratories Div Pfizer Inc |
| Route | ORAL | ORAL |
| Marketing Status | N/A | Prescription |